Skip to main content
. 2021 Jan 20;11:603947. doi: 10.3389/fneur.2020.603947

Figure 2.

Figure 2

Forest plot of OS in glioblastoma between lomustine plus bevacizumab and control groups. OS, overall survival; Lom, lomustine; Bev, bevacizumab.